Exhibit 4Option Agreement • August 16th, 1999 • Abbott Laboratories • Pharmaceutical preparations • Delaware
AGREEMENTAgreement • May 2nd, 2002 • Abbott Laboratories • Pharmaceutical preparations
Amendment Number 2 to Rights Agreement Pursuant to Section 27 of the Rights Agreement, dated as of November 11, 1999, by and between Abbott Laboratories, an Illinois corporation (the "Company") and BankBoston, N.A., a national banking association (the...Rights Agreement • May 19th, 2000 • Abbott Laboratories • Pharmaceutical preparations
SECTION 2 AMENDMENTS TO PURCHASE AGREEMENTPurchase Agreement • February 21st, 2002 • Abbott Laboratories • Pharmaceutical preparations
TRIANGLE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 11th, 1999 • Abbott Laboratories • Pharmaceutical preparations • Delaware
SECTION 401(k) PROFIT SHARING PLAN (NONSTANDARDIZED)Abbott Laboratories • November 30th, 2001 • Pharmaceutical preparations
EXHIBIT 25.1 ------------------------------------------------------------------ -------------- ---------------------------------------------------------------- ---------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549...Abbott Laboratories • September 16th, 1998 • Pharmaceutical preparations
ABBOTT LABORATORIES AND U.S. BANK NATIONAL ASSOCIATION, as TrusteeIndenture • March 10th, 2015 • Abbott Laboratories • Pharmaceutical preparations • New York
INDENTURE, dated as of March 10, 2015 between Abbott Laboratories, a corporation duly organized and existing under the laws of the State of Illinois (herein called the “Company”), having its principal office at 100 Abbott Park Road, Abbott Park, Illinois 60064-3500, and U.S. Bank National Association, a national banking association duly organized and existing under the laws of the United States of America, as Trustee (herein called the “Trustee”).
PURCHASE AGREEMENT THIS AGREEMENT is made as of the 30th day of January, 2001, by and between Triangle Pharmaceuticals, Inc. (the "Company"), a corporation organized under the laws of the State of Delaware, with its principal offices at 4 University...Purchase Agreement • February 16th, 2001 • Abbott Laboratories • Pharmaceutical preparations • New York
CONFIDENTIAL TREATMENT REQUESTED WORLDWIDE SALES, DISTRIBUTION, AND DEVELOPMENT AGREEMENT This Sales, Distribution, and Development Agreement (the "Agreement") is made as of December 21, 1999 by and between SuperGen, Inc., ("SuperGen"), a California...Confidential Treatment • January 5th, 2000 • Abbott Laboratories • Pharmaceutical preparations • Illinois
CONFIDENTIAL TREATMENT REQUESTED * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. WORLDWIDE SALES, DISTRIBUTION, AND DEVELOPMENT...Development Agreement • June 2nd, 2000 • Abbott Laboratories • Pharmaceutical preparations • Illinois
EXHIBIT 3Registration Rights Agreement • February 7th, 2000 • Abbott Laboratories • Pharmaceutical preparations • Delaware
RECITALSRegistration Rights Agreement • August 16th, 1999 • Abbott Laboratories • Pharmaceutical preparations • Delaware
TOAbbott Laboratories • February 12th, 2001 • Pharmaceutical preparations • New York
NOTARIAL DEEDPurchase Agreement • February 19th, 2003 • Abbott Laboratories • Pharmaceutical preparations
EXHIBIT 99.1 RIGHTS AGREEMENTRights Agreement • November 15th, 1999 • Abbott Laboratories • Pharmaceutical preparations • Illinois
dated as of August 3, 1998 2 THIS STANDSTILL AGREEMENT (the "Agreement") is made as of August 3, 1998, between i-STAT Corporation, a Delaware corporation (the "Company"), and Abbott Laboratories, an Illinois corporation ("Purchaser").Standstill Agreement • August 13th, 1998 • Abbott Laboratories • Pharmaceutical preparations • Delaware
EXHIBIT 2Stock Purchase Agreement • February 7th, 2000 • Abbott Laboratories • Pharmaceutical preparations • Delaware
AND COMPUTERSHARE TRUSTEES LIMITED TRUST DEED AND RULESAbbott Laboratories • January 10th, 2002 • Pharmaceutical preparations • England and Wales
PURCHASE AGREEMENTPurchase Agreement • February 15th, 2001 • Abbott Laboratories • Pharmaceutical preparations • Illinois
JOINT FILING AGREEMENTJoint Filing Agreement • March 26th, 1998 • Abbott Laboratories • Pharmaceutical preparations
In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13D (including amendments thereto) with respect to the common shares, without par value, of International Murex Technologies Corporation, and further agrees that this Joint Filing Agreement be included as an exhibit to such filings provided that, as contemplated by Section 13d-1(f)(l)(ii), no person shall be responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Joint Filing may be executed in any number of counterparts, all of which together shall constitute one and the same instrument.
RECITALSExclusive Distribution Agreement • September 1st, 1998 • Abbott Laboratories • Pharmaceutical preparations • California
EXHIBIT 4Credit Agreement • September 1st, 1998 • Abbott Laboratories • Pharmaceutical preparations • Delaware
STOCK PURCHASE AGREEMENT RIBOGENE, INC. MAY 29, 1998 TABLE OF CONTENTSStock Purchase Agreement • August 31st, 1998 • Abbott Laboratories • Pharmaceutical preparations • Delaware
1 EXHIBIT 99.A.3 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 13th, 1998 • Abbott Laboratories • Pharmaceutical preparations • New York
FIRST AMENDMENT TO TRIANGLE PHARMACEUTICALS, INC. STOCKHOLDER RIGHTS AGREEMENTStockholder Rights Agreement • August 8th, 2002 • Abbott Laboratories • Pharmaceutical preparations • Delaware
ABBOTT IRELAND FINANCING DAC AND ABBOTT LABORATORIES, as PARENT GUARANTOR AND U.S. BANK NATIONAL ASSOCIATION, as TrusteeIndenture • September 28th, 2018 • Abbott Laboratories • Pharmaceutical preparations • New York
INDENTURE, dated as of September 27, 2018 between Abbott Ireland Financing DAC, a designated activity company incorporated under the laws of Ireland (herein called the “Company”), having its registered office at 70 Sir John Rogerson’s Quay Dublin 2, Dublin, D02 R296, Ireland, Abbott Laboratories, a corporation duly organized and existing under the laws of the State of Illinois (herein called the “Parent Guarantor”), having its principal office at 100 Abbott Park Road, Abbott Park, Illinois 60064-3500 and U.S. Bank National Association, a national banking association duly organized and existing under the laws of the United States of America, as Trustee (herein called the “Trustee”).
SERIES E PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES E PREFERRED STOCK PURCHASE AGREEMENT (the "AGREEMENT") is made as of April 26, 1996 by and between RiboGene, Inc., a California corporation (the "COMPANY"), and Abbott Laboratories, an Illinois...Rights Agreement • August 31st, 1998 • Abbott Laboratories • Pharmaceutical preparations • California
Exhibit 2Stock Purchase Agreement • August 16th, 1999 • Abbott Laboratories • Pharmaceutical preparations • Delaware
ABBOTT LABORATORIES Debt Securities Underwriting AgreementUnderwriting Agreement • May 27th, 2010 • Abbott Laboratories • Pharmaceutical preparations • New York
EXHIBIT 10.6 AGREEMENT REGARDING CHANGE IN CONTROL THIS AGREEMENT ("Agreement"), is made and entered into as of the 20th day of June, 2003 (the "Effective Date") by and between Abbott Laboratories (the "Company") and _____________ (the "Executive")...Agreement Regarding Change in Control • August 12th, 2003 • Abbott Laboratories • Pharmaceutical preparations • Illinois
U.S. $5,000,000,000 FIVE YEAR CREDIT AGREEMENT Dated as of January 29, 2024 among ABBOTT LABORATORIES, as Borrower, and VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and JPMORGAN CHASE BANK, N.A., as Administrative Agent, andCredit Agreement • February 16th, 2024 • Abbott Laboratories • Pharmaceutical preparations • New York
ABBOTT LABORATORIES, a corporation organized and existing under the Laws of the State of Illinois (the “Borrower”), the Lenders (as defined below) that are parties hereto, and JPMorgan Chase Bank, N.A. (“JPMorgan”), as administrative agent (together with any successor thereto appointed pursuant to Article VII, the “Administrative Agent”) for the Lenders, agree as follows:
ABBOTT LABORATORIES PERFORMANCE RESTRICTED STOCK AGREEMENTPerformance Restricted Stock Agreement • February 19th, 2021 • Abbott Laboratories • Pharmaceutical preparations • Illinois
On «Grant_Date» (the “Grant Date”), Abbott Laboratories hereby grants to «First Name» «MI» «Last Name» (the “Employee”) a Performance Restricted Stock Award (the “Award”) of « NoShares12345» Shares.
ABBOTT LABORATORIES PERFORMANCE RESTRICTED STOCK UNIT AGREEMENTAbbott Laboratories Performance Restricted Stock Unit Agreement • April 28th, 2017 • Abbott Laboratories • Pharmaceutical preparations • Illinois
On this «Grant_Day» day of «Grant_Month», 201 (the “Grant Date”), Abbott Laboratories hereby grants to «First Name» «MI» «Last Name» (the “Employee”) a Performance Restricted Stock Unit Award (the “Award”) of «NoShares12345» restricted stock units (the “Units”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 15th, 2012 • Abbott Laboratories • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT dated November 8, 2012 (this “Agreement”) is entered into by and among AbbVie Inc., a Delaware corporation (the “Company”), Abbott Laboratories, an Illinois corporation (the “Guarantor”), and Morgan Stanley & Co. LLC, Barclays Capital Inc., J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated as representatives (collectively, the “Representatives”) of the initial purchasers listed in Schedule I to the Purchase Agreement (as defined below) (the “Initial Purchasers”).
